Delivery Order SPE2DB22D2005-SPE2DB26FJFA4
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order on July 30, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Ondansetron ODT 8 mg tablets in a 30-count quantity. This is a non-set-aside, competitively awarded firm fixed price delivery order with a ceiling value of $1,438.73 and an ultimate completion date of July 31, 2025. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $22,083.25 and an ultimate completion date of September 25, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $35,990.01. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of September 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Ondansetron ODT 4 MG tablets in a 30-count package, with a contract ceiling value of $2,166.52. This is a firm fixed-price delivery order with an ultimate completion date of October 23, 2025, and represents a non-competitive set-aside award. The performance location is the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 4, 2025, for Ondansetron ODT 8 mg tablets (30-count) with a ceiling value of $3,208.01. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 5, 2025. The order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child action under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units, with a contract ceiling value of $23,972.62. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of October 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This competitive, non-set-aside delivery order carries a ceiling value of approximately $15.1K with firm fixed pricing and is scheduled for completion by September 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and leverages its established...
- The Defense Logistics Agency awarded a $3,818.49 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count units) on September 9, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the agency. The product will be performed at the vendor's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $2,679.15. This competitively awarded, firm fixed-price delivery order is not set-aside and is set for completion by August 6, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,840.13 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Ondansetron ODT 8 mg tablets (30-count packages). This competitively awarded, firm fixed-price delivery order has an ultimate completion date of September 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's ability...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB26FJFA4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Ondansetron ODT 8 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $1,106.75. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of November 3, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, supplies a broad portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The firm fixed-price delivery order structure and modest ceiling value are consistent with the company's pattern of fulfilling routine pharmaceutical procurement requirements through the DLA Medical Supply Chain. As a prime contractor under the SPE2DX IDC, AmerisourceBergen has demonstrated the capability to meet federal procurement standards across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 10/31/25 |